Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
- 1 December 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 21 (10), 832-849
- https://doi.org/10.2174/1566524020999210101234317
Abstract
Diabetes mellitus (DM) is a chronic disease and threatening problem for world health. Allopathic medications are not efficient enough in controlling DM and its complications. Therefore, much attention has been directed towards the traditional medicine system. Plant derived-natural compounds with medicinal properties play an essential role in DM management and treatment. Artemisia is a varied and widespread genus of the family Asteraceae, which has more than 500 species with beneficial economic and therapeutic significance. Electronic databases such as Science Direct, Scopus, Pubmed, Web of Science, medRixv and Wiley were used to search scientific literatures. In folklore medicine, Artemisia species have been widely utilized for diabetes management. Molecular investigations have revealed that the NF-κB suppression, Notch 1 inhibition, cell cycle stop at S+G2/M-phase, enhanced Bax protein concentrations, mitochondrial membrane potential attenuation, activation of p53 and caspase, Bcl-2 regulation, and ROS formation are crucial mechanisms that could be targeted via various Artemisia species. Anti-diabetic effects of single or multiple doses of alcoholic and aqueous extracts of Artemisia species are due to presence of bioactive compounds, and they are completely efficient in lowering levels of blood glucose in experimental examinations. In spite of available anti-diabetic drugs, therapeutic agents obtained from mentioned plants have been used for the treatment of this disease and its complications with less adverse impacts. Taken together, multiple line of evidences indicated that Artemisia species could be introduced as potential therapeutic candidate in the treatment and management of diabetes.Keywords
This publication has 135 references indexed in Scilit:
- High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A proteases from Multiple Hepatitis C Virus GenotypesPLOS ONE, 2013
- Dried Whole Plant Artemisia annua as an Antimalarial TherapyPLOS ONE, 2012
- Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioactives from Artemisia dracunculus L.Journal of Proteomics, 2012
- Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactionsMalaria Journal, 2011
- Screening Natural Products for Inhibitors of Quinone Reductase-2 Using Ultrafiltration LC−MSAnalytical Chemistry, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- High-Fat Diet-Induced Neuropathy of Prediabetes and Obesity: Effect of PMI-5011, an Ethanolic Extract ofArtemisia dracunculusL.Mediators of Inflammation, 2010
- Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cellsJournal of Biomedical Science, 2009
- Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle cultureMetabolism, 2008
- Determination of the Chemical Composition and Antioxidant Activity of the Essential Oil of Artemisia dracunculus and of the Antifungal and Antibacterial Activities of Turkish Artemisia absinthium, A. dracunculus, Artemisia santonicum, and Artemisia spicigera Essential OilsJournal of Agricultural and Food Chemistry, 2005